Emory University: COVID-19 trials

The registry lists 15 COVID-19 studies with Emory University as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 1Phase 2 3Phase 3 3Phase 4 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Arginine Replacement Therapy in COVID-19RecruitingNCT05855330Phase 2
• Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q SystemEnrolling by invitationNCT04369599Not applicable
• Promoting Engagement and COVID-19 Testing for HealthCompletedNCT06141850Not applicableResults posted
• Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility TrialTerminatedNCT05946551Phase 3Results posted
• Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19CompletedNCT04912895Not applicableResults posted
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)CompletedNCT04487886Phase 2Results posted
• Therapeutic Plasma Exchange for COVID-19-associated HyperviscosityCompletedNCT04441996Phase 4Results posted
• Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19CompletedNCT04331366Not applicableResults posted
• Multisite Observational Maternal and Infant Study for COVID-19CompletedNCT05031468
• Remote Monitoring of COVID-19 Positive OutpatientsTerminatedNCT04853108
• Cetirizine and Famotidine for COVID-19WithdrawnNCT04836806Phase 4
• Convalescent Plasma in Pediatric COVID-19CompletedNCT04458363Early Phase 1
• Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19Active, not recruitingNCT04433949Phase 3
• Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19TerminatedNCT04366791Phase 1/2
• Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)WithdrawnNCT04361552Phase 3